Form 4: Iron Mountain Director Trades Under 10b5-1 Plan
Insider Transaction Report
Pamela M. Arway, a Director at Iron Mountain Inc., executed a transaction under a pre-established Rule 10b5-1 trading plan.
Summary
- Pamela M. Arway, a Director of Iron Mountain Inc. (IRM), reported a transaction on May 12, 2026.
- The transaction involved the sale of 1,892 shares of common stock at a price of $128.97 per share.
- This sale was conducted under a Rule 10b5-1 trading plan adopted by Ms. Arway on September 8, 2025.
- Following this transaction, Ms. Arway beneficially owns 40,196 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it involves a director selling shares, the transaction was conducted under a pre-arranged Rule 10b5-1 plan, mitigating concerns about opportunistic insider trading.
Negatives
- A director sold a portion of their holdings, which could be perceived negatively by the market, although it was executed under a pre-planned trading strategy.
Risks
- The Rule 10b5-1 plan is designed to mitigate insider trading concerns, but the sale itself represents a reduction in direct beneficial ownership by a director.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. The transaction was executed under a pre-existing trading plan.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to sell shares without facing insider trading accusations, indicating a structured approach to personal portfolio management.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Pamela M. Arway granted a Power of Attorney to Deborah Marson, Keely Stewart, and Luke Cummiskey to prepare, sign, and file Section 16 filings on her behalf. | 04/17/2023 | Ensures timely and compliant filing of required disclosures even if the reporting person is unavailable. |
Stakeholder Impact
- Shareholders: The sale, though planned, may lead to minor short-term sentiment shifts. The adherence to a 10b5-1 plan suggests a lack of adverse non-public information.
- Management: Demonstrates adherence to corporate governance and insider trading policies.
- Employees: The transaction does not directly impact employee stock options or benefits.
Next Steps
- The Rule 10b5-1 plan may continue to be executed in accordance with its terms.
- Future transactions under the plan will be reported on subsequent Form 4 filings.
Key Dates
| Date | Description |
|---|---|
| 04/17/2023 | Date of Power of Attorney granted by Pamela M. Arway. |
| 09/08/2025 | Date the Rule 10b5-1 trading plan was adopted by Pamela M. Arway. |
| 05/12/2026 | Transaction date for the sale of common stock. |
| 05/13/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Form 4, SEC Filing, Insider Trading, Rule 10b5-1, Iron Mountain, IRM, Director Transaction, Stock Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.